Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice

Metabolism: Clinical and Experimental

Volumn 50, Issue 5, 2001, Pages 530-536

  Berti, J A ^b   Amaral, M E C ^b   Boschero, A C ^b   Nunes, V S ^b   Harada, L M ^b   Castilho, L N ^b   Oliveira, H C F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL DERIVATIVE; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIOTHYRONINE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; PROPYLTHIOURACIL; THYROID HORMONE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; HYPERTHYROIDISM; HYPOTHYROIDISM; ISOTOPE DILUTION ASSAY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE; SMALL INTESTINE; THYROID DISEASE; TISSUE LEVEL; TRANSGENIC MOUSE;

EID: 0035340049     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.22514     Document Type: Article

References (52)

1. 1. Kuusi T, Taskinen MR, Nikkila EA: Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 66:51-56, 1988
2. 2. Abrams JJ, Grundy SM: Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res 22:323-338, 1981
3. 3. Vanhaelst L, Neve P, Bastenie PA: Coronary-artery disease in myxoedema. Lancet 9:1257-1258, 1967
4. 4. Bastenie PA, Vanhaelst L, Neve P: Coronary-artery disease in hypothyroidism. Lancet 2:1221-1222, 1967
5. 5. Muls E, Blaton V, Rosseneu M, et al: Serum lipids and lipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab 55:459-464, 1982
6. 6. Friis T, Pedersen LR: Serum lipids in hyper- and hypothyroidism before and after treatment. Clin Chim Acta 162:155-163, 1987
7. 7. Kung AW, Pang RW, Lauder I, et al: Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem 41:226-231, 1995
8. 8. Thompson GR, Soutar AK, Spengel FA, et al: Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 78:2591-2595, 1981
9. 9. Staels B, Van Tol A, Chan L, et al: Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 127:1144-1152, 1990
10. 10. Salter AM, Hayashi R, Al-Seeni M, et al: Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA: Cholesterol acyltransferase activities in rat liver. Biochem J 276:825-832, 1991
11. 11. Muls E, Russeneu M, Blanton V, et al: Serum lipids and apolipoprotein A-I, A-II and B in primary hypothyroidism before and during treatment. Eur J Clin Invest 14:12-15, 1984
12. 12. Scottolini AG, Bhagavan NV, Oshiro TH, et al: Serum high-density lipoprotein cholesterol concentrations in hypo- and hyperthyroidism. Clin Chem 26:584-587, 1980
13. 13. Valdemarsson S: Plasma lipoprotein alterations in thyroid dysfunction. Roles of lipoprotein lipase, hepatic lipase and LCAT. Acta Endocrinol 103:1-52, 1983 (suppl 255)
14. 14. Verdugo C, Perrot L, Ponsin G, et al: Time-course of alterations of high density lipoproteins (HDL) during thyroxine administration to hypothyroid women. Eur J Clin Invest 17:313-316, 1987
15. 15. Agdeppa D, Macaron C, Mallik T, et al: Plasma high density lipoprotein cholesterol concentration in thyroid disease. J Clin Endocrinol Metabol 49:726-729, 1979
16. 16. Nishitani H, Okamura K, Noguchi S, et al: Serum lipid levels in thyroid dysfunction with special reference to transient elevation treatment in hyperthyroidism Graves' disease. Horm Metab Res 22:490-493, 1990
17. 17. Heimberg M, Olubadewo JO, Wilcox HG: Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev 6:590-607, 1985
18. 18. Wilcox HG, Frank RA, Heimberg M: Effects of thyroid status and fasting on hepatic metabolism of apolipoprotein A-I. J Lipid Res 32:395-405, 1991
19. 19. Mooradian AD, Wong NG, Sahah GN: Age-related changes in the responsiveness of apolipoprotein AI to thyroid hormone. Am J Physiol 271:R1602-R1607, 1996
20. 20. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 34:1255-1274, 1993
21. 21. Marotti KR, Castle CK, Boyle TP, et al: Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature (Lond) 364:73-75, 1993
22. 22. Zhong S, Sharp DS, Grove JS, et al: Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 15:2917-2923, 1996
23. 23. Tan KCB, Shiu SWM, Kung WC: Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism. J Clin Endocrinol Metab 83:140-143, 1998
24. 24. Dullaart RP, Hoogenber GK, Groener JE, et al: The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: A possible contribution to alterations in high-density lipoproteins. Eur J Clin Invest 20:581-587, 1990
25. 25. Ritter MC, Kannan CR, Bagdade JD: The effects of hypothyroidism and replacement therapy on cholesteryl ester transfer. J Clin Endocrinol Metab 81:797-800, 1996
26. 26. Applebaum-Bowden D: Lipases and lecithin: Cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol 6:130-135, 1995
27. 27. Santamarina-Fojo S, Haudenschild C, Amar M: The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 9:211-219, 1998
28. 28. Tan KCB, Shiu SWM, Kung AWC: Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: Roles of hepatic lipase and cholesteryl ester transfer protein. J Clin Endocrinol Metab 83:2921-2924, 1998
29. 29. Valdemarsson S, Hedner P, Nilsson-Ehle P: Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism. Eur J Clin Invest 12:423-428, 1982
30. 30. Jiang XC, Agellon LB, Walsh A, et al: Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. J Clin Invest 90:1290-1295, 1992
31. 31. Oliveira HCF, Chouinard RA, Agellon, LB, et al: Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5'-distal sequences. J Biol Chem 271:31831-31838, 1996
32. 32. Masucci-Magoulas L, Moulin P, Jiang XC, et al: Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolyssaccharide administration in human CETP transgenic mice. J Clin Invest 95:1587-1594, 1995
33. 33. Masucci-Magoulas L, Plump A, Jiang XC, et al: Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. J Clin Invest 97:154-161, 1996
34. 34. De Luise M, Harker M: Skeletal muscle metabolism effect of age, obesity, thyroid and nutritional status. Horm Metab Res 21:410-415, 1989
35. 35. Murase T, Uchimura H: A selective decline of postheparin plasma hepatic triglyceride lipase in hypothyroid rats. Metabolism 29:797-801, 1980
36. 36. Zerbinatti CV, Oliveira HCF, Wechesler S, et al: Independent regulation of chylomicron lipolysis and particle removal rates: Effects of insulin and thyroid hormones on the metabolism of artificial chylomicrons. Metabolism 40:1122-1127, 1991
37. 37. Jiao S, Cole TG, Kitchens RT, et al: Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography. Metabolism 39:155-160, 1990
38. 38. Folch J, Lees M, Sloane Stanley GH: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 224:497-509, 1957
39. 39. Ehnholm C, Kuusi T: Preparation, characterization and measurement of hepatic lipase. Methods Enzymol 129:716-738, 1986
40. 40. Motomura K, Brent GA: Mechanisms of thyroid hormone action. Endocr Metab Clin North Am 27:1-23, 1998
41. 41. Dieckman MJM, Vogelaar J, Stalenhoef AFH, et al: Increased oxidazibility of low density lipoproteins in hypothyroidism. J Endocrinol Invest 20:29, 1997 (suppl, abstr 57)
42. 42. Benenga S: Effect of thyroxine on low density lipoprotein oxidation. Another thyroid hormone nongenomic effect. J Clin Endocrinol Metab 83:3777-3778, 1998
43. 43. McPherson R, Mann CJ, Tall AR, et al: Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 11:797-804, 1991
44. 44. Jokinen EV, Landschulz KT, Wyne KL, et al: Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 269:26411-26418, 1994
45. 45. Tall A, Sammett D, Granot E: Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest 77:1163-1172, 1986
46. 46. Bijvoet S, Gagne SE, Moorjani S, et al: Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res 37:640-650, 1996
47. 47. Wilson JD, Foster DW, Kronenberg HM, et al: Williams Textbook of Endocrinology. Philadelphia, PA, Saunders, 1998
48. 48. Collet X, Tall AR, Serajuddin H, et al: Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res 40:1185-1193, 1999
49. 49. Harada LM, Cazita PM, Nunes VS, et al: HDL-cholesteryl ester plasma removal and tissue uptake in CETP transgenic and non-transgenic mice. Atherosclerosis 150:S14, 2000 (suppl 2, abstr P11)
50. 50. Landschulz KT, Pathak RK, Rigotti A, et al: Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 98:984-995, 1996
51. 51. Field FJ, Albright E, Mathur SN: The effect of hypothyroidism and thyroxine replacement on hepatic and intestinal HMG-CoA reductase and ACAT activities and biliary lipids in the rat. Metabolism 35:1085-1089, 1986
52. 52. Strobl W, Gorder NL, Lin-Lee YC, et al: Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver. J Clin Invest 85:659-667, 1990 10